Antiviral prophylaxis to prevent herpes simplex virus (HSV) and varicella zoster virus (VZV) reactivation in adult patients with newly diagnosed acute leukemia: results of a survey submitted to Italian centers belonging to SEIFEM (Sorveglianza Epidemiologica Infezioni nelle Emopatie) group-Reference-Cited by-同舟云学术

Antiviral prophylaxis to prevent herpes simplex virus (HSV) and varicella zoster virus (VZV) reactivation in adult patients with newly diagnosed acute leukemia: results of a survey submitted to Italian centers belonging to SEIFEM (Sorveglianza Epidemiologica Infezioni nelle Emopatie) group

Published:2024-08-08 Issue: Volume: Page:
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Forghieri Fabio^ORCID,Cordella Stefano,Marchesi Francesco,Itri Federico,Del Principe Maria Ilaria,Cavalieri Elena,Pasciolla Crescenza,Bonanni Matteo,Criscuolo Marianna,Fiorentini Alessandro,Guolo Fabio,Buquicchio Caterina,Prezioso Lucia,Delia Mario,Melillo Lorella,Audisio Ernesta,Zannier Maria Elena,Cerchione Claudio,Dargenio Michelina,Cattaneo Chiara,Fracchiolla Nicola Stefano,Pezone Sara,Perruccio Katia,Santoni Adele,Candoni Anna,Vignetti Marco,Luppi Mario,Pagano Livio,Busca Alessandro

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s00277-024-05927-1.pdf

Reference15 articles.

1. Henze L, Buhl C, Sandherr M, Cornely OA, Heinz WJ, Khodamoradi Y, Kiderlen TR, Koehler P, Seidler A, Sprute R, Schmidt-Hieber M, von Lilienfeld-Toal M (2022) Management of herpesvirus reactivations in patients with solid tumours and hematologic malignancies: update of the guidelines of the infectious diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO) on herpes simplex virus type 1, herpes simplex virus type 2, and varicella zoster virus. Ann Hematol 101(3):491–511. https://doi.org/10.1007/s00277-021-04746-y

2. Girmenia C, Ciceri F, Corradini P, Cuneo A, D’Ancona F, Musto P, Risitano AM, Voso MT, Venditti A, Barosi G (2023) Towards a personalized preventive strategy of herpes zoster infection in patients with hematologic diseases or hematopoietic stem cell transplant recipients: a position paper from an ad hoc Italian expert panel. Haematologica 2023 Dec 14. https://doi.org/10.3324/haematol.2023.284417

3. Freyer CW, Peterson CE, Man Y, Przespolewski A, Baron J, Luger SM (2021) Herpes zoster during arsenic trioxide therapy for acute promyelocytic leukemia. Leuk Lymphoma 62(3):696–702. https://doi.org/10.1080/10428194.2020.1838507

4. Glass JL, Derkach A, Hilden P, King A, Seo SK, Ahr K, Kishtagari A, Levine RL, Tallman MS, Douer D (2021) Arsenic trioxide therapy predisposes to herpes zoster reactivation despite minimally myelosuppressive therapy. Leuk Res 106:106569. https://doi.org/10.1016/j.leukres.2021.106569

5. Yahav D, Gafter-Gvili A, Muchtar E, Skalsky K, Kariv G, Yeshurun M, Leibovici L, Paul M (2009) Antiviral prophylaxis in haematological patients: systematic review and meta-analysis. Eur J Cancer 45(18):3131–3148. https://doi.org/10.1016/j.ejca.2009.08.010